We publish our pricing. £1,500 a month per molecule. See it here →
01 · Changelog

What we shipped.

One month, one section. Data refreshes, new views, and the occasional bug we owned up to. No marketing beats. No "we're excited to announce".

September 2026
26 changes
  • 28 Sep
    Added
    Line history. Every NHS framework line now has a history in each buying group: each award since 2016 with its holder and dates, each edition of NHS England's generics workplan we hold, and the tenders you imported. Holder changes, end dates that moved and lines re-tendered ahead of time are written out in words. Across the award history, lines changed holder 7,022 times, and 710 were awarded again while an earlier award was still running, most of them in the housekeeping and supply-chain resilience frameworks. It is on the Tender Desk line page and behind a "history" link on every hospital pack. When a line in your catalogue or on one of your tenders changes, you get a notification and a line in your daily email. NHS England does not publish when a holder hands a line back; a line re-tendered ahead of time is the visible sign, and we say so. The bell at the top of the app now lists your notifications.
  • 28 Sep
    Changed
    Hospital prices now come as a range, not just an average. eMIT publishes an average price per pack and a standard deviation, and when trusts paid very different prices the average describes no real trust. The Hospital tab, the Tender Desk and the bid workbook now show the average plus and minus one standard deviation, and say how wide the spread is: in the June 2026 release it is wide for 29% of packs, and for 11% the spread is as large as the average or larger, so no range is shown and the page says the average is a poor guide. On a tender line we also say which months the price covers (March to June 2026 for the current release) and whether they fall under the line's current framework award or the one before it.
  • 27 Sep
    Added
    Framework awards now cover NHS England's branded medicines frameworks, biosimilars among them: 96 award schedules published since March 2019 and about 6,700 award lines, 1,695 of them in force today across 1,359 product lines. For the molecules DoseTrend tracks, 37 now show who holds a current branded award, adalimumab and insulin glargine, aspart and lispro among them. Branded frameworks buy through their own groups (Pan London, South of England, North of England, Midlands and East, and National), and the Hospital tab names each one. NHS England can extend a branded framework without publishing the extension line by line, so where a branded award has ended with nothing published after it, the page says it may still be running.
  • 27 Sep
    Data
    Framework award history now goes back to 2016. We had said that frameworks awarded before the Procurement Act 2023 published no line awards. They did, on Contracts Finder rather than Find a Tender, and they are now loaded: 83 more schedules and about 30,000 award lines from July 2016. The Hospital tab, Framework awards and the Tender Desk now show the published award behind 98% of the lines and buying groups on NHS England's June 2026 generics workplan, up from 22%. Awards made between 2021 and mid 2022 were published without line awards, and the pages say so where that applies.
  • 26 Sep
    Added
    Market tab: manufacturing sites named by regulators. When an EU authority issues a statement that a manufacturing site does not comply with good manufacturing practice, or the US FDA sends a manufacturing warning letter, and the document names a product of a molecule you follow, it now appears as an event abroad on the chart and in a table on the Market tab: the site, its country, the products named and whether the matter is still open. The first load covers 79 EU statements in force and 350 FDA letters since 2021, and puts 37 reviewed events on 29 molecules, eight of them at one Indian site. Neither regulator says whether a site supplies the UK, and the table says so.
  • 26 Sep
    Added
    Trend tab: people, not just items. For about 30 molecules NHSBSA publishes how many people were prescribed them, and the Trend tab now shows it: identified patients by financial year from 2016/17, items per patient, the latest month, and for mental health medicines the ICBs with the most and fewest patients per 1,000 registered. The public molecule page carries the latest year in one sentence. Covers antidepressants, antipsychotics, hypnotics, ADHD medicines, opioids, gabapentinoids, benzodiazepines and the GLP-1 and SGLT-2 diabetes medicines.
  • 25 Sep
    Added
    Market tab: where it is dispensed. The share of each molecule dispensed by community pharmacies, dispensing doctors, appliance contractors and personal administration, monthly from January 2021, and the dispensing-doctor share in each ICB. For molecules pharmacists supply under a national service, such as nitrofurantoin under Pharmacy First, the items supplied each month from February 2024. Those supplies are not in GP prescribing data, and the trend and the public molecule page now say how many there were.
  • 25 Sep
    Added
    Your own molecules in your AI assistant. Subscribers sign in to DoseTrend from Claude, ChatGPT or any MCP client that supports sign-in, and the connector answers from their own molecules with everything their workspace shows: the full trend, every ICB, prescribing organisations, market share, hospital usage and prices, framework holders, signals and the monthly briefing. The same tier locks apply as on the web. Password, two-factor and single sign-on all work, and the assistant never sees your password. See and disconnect connected assistants under Settings, AI assistants.
  • 25 Sep
    Added
    SAML single sign-on, included on Molecule and Portfolio at no extra cost. Owners and admins connect Microsoft Entra ID, Okta, Google Workspace or any SAML 2.0 provider under Settings, SSO & security: paste the metadata, verify the email domain by DNS, test, and switch on. Accounts are created on first sign-in with the role and group you choose, and owners can enforce single sign-on for everyone else.
  • 25 Sep
    Changed
    Until today the pricing and platform pages listed SAML before it existed. It exists now; we have also corrected the pages that said it came with every plan.
  • 25 Sep
    Added
    DoseTrend in your AI assistant. Connect Claude, ChatGPT, Microsoft Copilot or any MCP client to dosetrend.com/connector and ask about any molecule we track in plain English. Answers carry the data month, the caveats and the NHS source. Free for the public figures, no account needed, and included in every plan. Setup guide at /assistants.
  • 23 Sep
    Added
    Hospital tab: framework holders. Who won each hospital framework line in each NHS England buying group, with the award share, usage estimate and dates, from the award schedules NHS England publishes on Find a Tender. Frameworks awarded before the Procurement Act 2023 published no line-by-line schedule, and the tab says so.
  • 23 Sep
    Added
    Framework awards, a new page under Intelligence: who won each NHS England generics framework line for your molecules, by buying group, and how many awarded lines sit on the molecules you do not track yet.
  • 23 Sep
    Added
    Tender Desk: the current holder of every line in every tendered region, a filter for lines with a published holder, and the holder in the bid workbook. Signals: an event when a framework award for your molecule is published.
  • 22 Sep
    Added
    Products on the market, on the Market tab: every supplier, product, pack, GTIN and published list price for your molecule from the NHS dictionary of medicines (dm+d), refreshed each week, with what changed since the last release. A listing means a product may be supplied; it says nothing about sales.
  • 22 Sep
    Added
    Hospital tab: issues by strength and form, each in its own unit, and by the nine NHS England generics tender regions.
  • 22 Sep
    Added
    Prices tab and hospital benchmark: the dm+d list price range beside the tariff and eMIT prices on every priced pack.
  • 22 Sep
    Added
    Signals: an event when a supplier lists its first product for a molecule, discontinues its last pack, or moves a list price by 15% or more.
  • 22 Sep
    Added
    Public molecule pages now say who supplies each molecule.
  • 22 Sep
    Data
    Hospital dispensing is now matched by dm+d product code rather than product name, back to November 2020. Combination products no longer count towards a single molecule, which matches how primary care is counted.
  • 22 Sep
    Added
    Tender Desk: hospital usage for each line per tender region, licence number lookup from the MHRA product index, and a company profile that fills the questionnaire once.
  • 21 Sep
    Added
    Tender Desk: import an NHS generics tender schedule, work every line as a team with sign-offs and comments, pre-fill from your catalogue and from dm+d, and export the workbook, keying sheet and consistency report.
  • 14 Sep
    Changed
    Applying for access is read-the-form: no call to book.
  • 6 Sep
    Added
    Prices tab: Drug Tariff, hospital price paid and price concession history per pack on one dated chart.
  • 5 Sep
    Data
    Added hospital prices paid (DHSC eMIT), scheduled framework end dates (NHS England workplan), suppliers named on prescriptions (NHSBSA PCA), MHRA marketing authorisations and DHSC price concessions.
  • 1 Sep
    Added
    Signals: dated events on the trend chart with the verbatim source quote and link, a feed page, alert emails and a weekly digest. Every event is reviewed by a person before it is shown.
August 2026
4 changes
  • 25 Aug
    Changed
    Alerts and exports follow the tier: Snapshot sees dates and types, paid tiers see everything.
  • 23 Aug
    Changed
    Sign-in is email, password and an authenticator code. Google and Microsoft sign-in removed.
  • 22 Aug
    Added
    Monthly briefings as PDF, and a print view.
  • 15 Aug
    Changed
    DoseTrend is operated by Hotline Labs Ltd. Terms, privacy and invoices updated.
July 2026
9 changes
  • 24 Jul
    Data
    Scotland, Wales and Northern Ireland prescribing data, and defined daily dose normalisation where the WHO publishes one.
  • 24 Jul
    Added
    Glossary and alternatives pages.
  • 19 Jul
    Data
    Quantity and cost per item, brand, generic and biosimilar split, class market share, QOF treatment context and the deprivation gradient, on every molecule.
  • 17 Jul
    Changed
    Personal data is encrypted at rest.
  • 12 Jul
    Added
    Bot protection on every public form, and email delivery tracking.
  • 10 Jul
    Added
    Customer billing page (/app/billing) with viewable and downloadable invoices.
  • 9 Jul
    Added
    Update payment method inline, with card validation and success/error toasts.
  • 5 Jul
    Changed
    Fleshed out the internal finance console: MRR, dunning queue, and refund workflow.
  • 2 Jul
    Data
    NHSBSA English Prescribing Data refreshed to May 2026.
June 2026
4 changes
  • 28 Jun
    Added
    Sources page /app/sources: last-updated timestamps and per-dataset change log.
  • 20 Jun
    Added
    Cookie consent banner honouring the analytics choice.
  • 12 Jun
    Changed
    Simplified pricing page: fewer footnotes, clearer per-molecule pricing.
  • 5 Jun
    Fixed
    ICB tables no longer double-count practices that moved organisation mid-month.
May 2026
3 changes
  • 30 May
    Added
    Sample report /sample: full apixaban briefing, no email wall.
  • 18 May
    Data
    Secondary Care Medicines Data refreshed to March 2026.
  • 8 May
    Changed
    Molecule detail page: added five-year trend chart above the fold.